CA1282077C - Process for producing substituted-phenethylamine derivatives - Google Patents

Process for producing substituted-phenethylamine derivatives

Info

Publication number
CA1282077C
CA1282077C CA000515041A CA515041A CA1282077C CA 1282077 C CA1282077 C CA 1282077C CA 000515041 A CA000515041 A CA 000515041A CA 515041 A CA515041 A CA 515041A CA 1282077 C CA1282077 C CA 1282077C
Authority
CA
Canada
Prior art keywords
group
compound
salt
lower alkyl
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000515041A
Other languages
English (en)
French (fr)
Inventor
Kunihiro Niigata
Takashi Fujikura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17263445&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA1282077(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of CA1282077C publication Critical patent/CA1282077C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA000515041A 1985-11-13 1986-07-31 Process for producing substituted-phenethylamine derivatives Expired - Lifetime CA1282077C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP254,326 1985-11-13
JP60254326A JPS62114952A (ja) 1985-11-13 1985-11-13 置換フエネチルアミン誘導体の製造法

Publications (1)

Publication Number Publication Date
CA1282077C true CA1282077C (en) 1991-03-26

Family

ID=17263445

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000515041A Expired - Lifetime CA1282077C (en) 1985-11-13 1986-07-31 Process for producing substituted-phenethylamine derivatives

Country Status (5)

Country Link
JP (1) JPS62114952A (ko)
KR (1) KR940007746B1 (ko)
AT (1) AT397960B (ko)
CA (1) CA1282077C (ko)
ES (1) ES2000382A6 (ko)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005080323A1 (en) * 2004-02-23 2005-09-01 Cadila Healthcare Limited Process for manufacturing optically pure (r) or (s)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide
WO2007031823A1 (en) * 2005-09-12 2007-03-22 Aurobindo Pharma Limited An improved process for preparing tamsulosin hydrochloride
EP1786764A2 (en) 2004-08-16 2007-05-23 Scinopharm Singapore Pte Ltd. Process for preparing tamsulosin
US7329780B2 (en) 2003-12-09 2008-02-12 Cj Corporation Method of preparing optically pure phenethylamine derivatives
WO2008152653A2 (en) * 2007-06-11 2008-12-18 Matrix Laboratories Ltd An improved process for the preparation of tamsulosin hydrochloride
RU2456269C2 (ru) * 2003-12-29 2012-07-20 Лек Фармасьютикалз Д.Д. Получение r-5-(2-(2-(2-этоксифенокси)этиламино)пропил)-2-метоксибензолсульфонамидгидрохлорида высокой химической чистоты
JP2013504563A (ja) * 2009-09-12 2013-02-07 サンド・アクチエンゲゼルシヤフト インドリン誘導体の調製方法およびこれらの中間体
DE202023102187U1 (de) 2023-04-25 2023-05-02 Nusrath Anjum Auf Tamsulosin basierende Derivatformulierung

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971990A (en) * 1988-02-19 1990-11-20 Hokuriku Pharmaceutical Co., Ltd. Phenoxyethylamine derivatives, for preparing the same and composition for exhibiting excellent α1 -blocking activity containing the same
US5288759A (en) * 1992-08-27 1994-02-22 Alcon Laboratories, Inc. Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
KR100525493B1 (ko) * 2001-02-23 2005-11-02 연성정밀화학(주) 설파모일 치환 페네틸아민 유도체의 제조 방법
CZ20013848A3 (cs) * 2001-10-25 2003-05-14 Léčiva, A.S. Způsob výroby (R)-(-)-5-[2-[2-(2-ethoxyfenoxy)ethylamino]propyl]-2-methoxybenzensulfonamidu
ES2200699B1 (es) * 2002-07-12 2005-10-01 Ragactives, S.L Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.
WO2004016582A1 (en) * 2002-08-14 2004-02-26 Natco Pharma Limited An improved process for the preparation of tamsulosin hydrochloride
KR100503639B1 (ko) 2003-02-12 2005-07-26 보령제약 주식회사 탐술로신의 정제 방법
SI21655A (sl) * 2003-12-29 2005-06-30 LEK farmacevtska dru�ba d.d. Sinteza optično čistega (R)-5-(2-aminopropil)-2-metoksibenzensulfonamida
CZ295583B6 (cs) * 2004-02-05 2005-08-17 Zentiva, A. S. Způsob výroby (R)-(-)-5-(2-aminopropyl)-2-methoxybenzensulfonamidu
WO2006004093A1 (ja) * 2004-07-07 2006-01-12 Hamari Chemicals, Ltd. 光学活性フェニルプロピルアミン誘導体の製法
ES2603747T3 (es) 2009-02-04 2017-03-01 Astellas Pharma Inc. Composición farmacéutica para administración oral
EP2255793A1 (en) 2009-05-28 2010-12-01 Krka Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical composition comprising tamsulosin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
US4558156A (en) * 1980-02-08 1985-12-10 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7329780B2 (en) 2003-12-09 2008-02-12 Cj Corporation Method of preparing optically pure phenethylamine derivatives
RU2456269C2 (ru) * 2003-12-29 2012-07-20 Лек Фармасьютикалз Д.Д. Получение r-5-(2-(2-(2-этоксифенокси)этиламино)пропил)-2-метоксибензолсульфонамидгидрохлорида высокой химической чистоты
WO2005080323A1 (en) * 2004-02-23 2005-09-01 Cadila Healthcare Limited Process for manufacturing optically pure (r) or (s)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide
EP1786764A2 (en) 2004-08-16 2007-05-23 Scinopharm Singapore Pte Ltd. Process for preparing tamsulosin
EP1786764B1 (en) * 2004-08-16 2017-03-15 Scinopharm Singapore Pte Ltd. Process for preparing tamsulosin
WO2007031823A1 (en) * 2005-09-12 2007-03-22 Aurobindo Pharma Limited An improved process for preparing tamsulosin hydrochloride
US8273918B2 (en) 2005-09-12 2012-09-25 Avrobindo Pharma Ltd. Process for preparing tamsulosin hydrochloride
WO2008152653A2 (en) * 2007-06-11 2008-12-18 Matrix Laboratories Ltd An improved process for the preparation of tamsulosin hydrochloride
WO2008152653A3 (en) * 2007-06-11 2010-04-29 Matrix Laboratories Ltd An improved process for the preparation of tamsulosin hydrochloride
JP2013504563A (ja) * 2009-09-12 2013-02-07 サンド・アクチエンゲゼルシヤフト インドリン誘導体の調製方法およびこれらの中間体
DE202023102187U1 (de) 2023-04-25 2023-05-02 Nusrath Anjum Auf Tamsulosin basierende Derivatformulierung

Also Published As

Publication number Publication date
ES2000382A6 (es) 1988-02-16
KR940007746B1 (ko) 1994-08-24
KR870004949A (ko) 1987-06-02
ATA203286A (de) 1993-12-15
JPH0137391B2 (ko) 1989-08-07
JPS62114952A (ja) 1987-05-26
AT397960B (de) 1994-08-25

Similar Documents

Publication Publication Date Title
CA1282077C (en) Process for producing substituted-phenethylamine derivatives
JPH052678B2 (ko)
JPS6214540B2 (ko)
JP2015151395A (ja) アドレナリン拮抗薬の調製方法
JPH0662519B2 (ja) 環状中間体を用いたフエノ−ルエ−テルの製法
CZ1494A3 (en) Process for preparing diphenyl derivatives, aromatic compound and its use
JP6851149B2 (ja) ピペリジン化合物の製造方法
ES2330479T3 (es) Procedimiento para la preparacion de duloxetina.
JP2006514651A (ja) １−アルキル−３−アミノインダゾール
JPS58189132A (ja) ブテン誘導体の製造方法
FR2470758A1 (fr) Procede pour la fixation de groupes alkyles sur une chaine carbonee portant un groupe fonctionnel
TWI796701B (zh) 用於製備雜環化合物的中間體立體選擇性合成
JPH0430387B2 (ko)
WO2016146040A1 (en) Industrial method for production of 3,7-di-tert-butyl-s-(trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate
JPS5915901B2 (ja) ｕ↓−アミノアルコ−ルの製造方法
AU2001259052A1 (en) A process for preparing biphenyl compounds
EP1294683A2 (en) A process for preparing biphenyl compounds
TWI361807B (en) Process for preparing substituted 4-alkoxycarbonyl-3-aminothiophenes
TW200405809A (en) Process for preparing (S)-(+)-2-(substituted phenyl)-2-hydroxy-ethyl carbamates
JP2000507970A (ja) キラルメディエータの効率的な合成
JPH02290851A (ja) ２―クロロ―５―アミノメチルーピリジンの製造方法
JPH0472818B2 (ko)
JP2001520646A (ja) 新規な製造法
JP7128629B2 (ja) ルビプロストンの製造方法
JPH06102656B2 (ja) ラニチジンの製法

Legal Events

Date Code Title Description
MKEX Expiry